|
WuXi PharmaTech Stage: Growth Date of Investment: 2008 Web Site : http://www.wuxiapptec.com Stock Symbol : NYSE: WX |
 |
WuXi, headquartered in Shanghai, is a premier contract research organization ("CRO") with operations in China and the United States. The Company was founded in 2000 as a provider of outsourced research chemistry lab services to the pharmaceutical industry and has grown rapidly to become the global leader in this field. WuXi has expanded this core Lab Service business to include biology services and has developed emerging capabilities in the related areas of Clinical and Commercial Manufacturing, and Toxicology. Warburg Pincus became a significant shareholder in WuXi beginning in 2008.
